Back
Veracyte Vs. Dave Industry Stock Comparison
Sell
49
VCYT
Veracyte
Last Price:
$39.39
Seasonality Move:
-4.5%
Buy
67
DAVE
Dave
Last Price:
$101.18
Seasonality Move:
-8.43%
Sell
49
Veracyte (VCYT)
is a Sell
Is Veracyte a Buy, Sell or Hold?
-
VCYT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVE Stock Price Chart
VCYT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 40.7 | Sell |
Chaikin Money Flow: | -475765 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.68 - 44.5) | Sell |
Bollinger Bands (100): | (35.27 - 43.41) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.12 | Buy |
Relative Strength Index (14 RSI): | 49.52 | Sell |
Chaikin Money Flow: | -561677 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.43 - 109.31) | Buy |
Bollinger Bands (100): | (51.78 - 101.28) | Buy |
VCYT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.6 | Sell |
20-day SMA: | 42.61 | Sell |
50-day SMA: | 42.17 | Sell |
200-day SMA: | 32.38 | Buy |
8-day EMA: | 40.89 | Sell |
20-day EMA: | 41.77 | Sell |
50-day EMA: | 41.48 | Sell |
200-day EMA: | 34.81 | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 109.84 | Sell |
20-day SMA: | 102.65 | Sell |
50-day SMA: | 95.06 | Buy |
200-day SMA: | 57.37 | Buy |
8-day EMA: | 108.15 | Sell |
20-day EMA: | 103.84 | Sell |
50-day EMA: | 94.3 | Buy |
200-day EMA: | 63.98 | Buy |
Veracyte Earnings Growth & VCYT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.28 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $1.09 per share.
Veracyte Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |